Medreleaf (LEAF) made a huge move today, signing a supplier agreement with giant Shoppers Drug Mart. Last month Aphria(APH) also signed a supplier agreement with Shoppers Drug Mart, it looks as though they will be aggressive on the rec side of the sector moving forward.


Subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed producer, under the terms of the agreement the Company will supply Shoppers Drug Mart with MedReleaf branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.

“From inception, MedReleaf has been focused on setting the standard for patient care in our industry and producing consistent, high quality medicine,” said Neil Closner, CEO of MedReleaf. “With this agreement, we look forward to making our award-winning strains available as the trusted provider of premium cannabis-based pharmaceutical products to the largest pharmacy retailer in Canada.”